Asfar Azmi, PhD, discusses the tricomplex mechanism of daraxonrasib and its impact on overall survival for patients with pancreatic cancer.
Asfar Azmi, PhD
Advertisement
Articles by Asfar Azmi, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
2
What is The State of Radiation Oncology in Head and Neck Cancers?
3
Combining a PCNA Inhibitor with KRAS-Targeting Agents in PDAC
4
Elranatamab Significantly Improves PFS in R/R Multiple Myeloma Trial
5